Rho, Italy

Marco Torri


 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1995-2015

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Marco Torri: Innovator in Pharmaceutical Sciences

Introduction

Marco Torri is a distinguished inventor based in Rho, Italy, known for his significant contributions to pharmaceutical sciences. With a total of nine patents to his name, he has made remarkable advancements in the field, particularly in the development of new pharmaceutical compositions and methods.

Latest Patents

Among his latest patents, Torri has developed crystalline forms of rostafuroxin, specifically new forms B, C, D, E, and H. These forms are described alongside pharmaceutical compositions containing them and methods for their preparation. Additionally, he has created new diterpenoid derivatives that possess biological properties, aimed at treating cardiovascular disorders, urinary incontinence, asthma, and Alzheimer's disease. These inventions also focus on preventing obstructive vascular lesions following arteriotomy and angioplasty, as well as preventing organ damage in hypertensive patients.

Career Highlights

Throughout his career, Marco Torri has worked with notable companies such as Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Rostaquo S.p.a. His work in these organizations has allowed him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Torri has collaborated with esteemed colleagues, including Mauro Gobbini and Patrizia Ferrari, contributing to the advancement of innovative pharmaceutical solutions.

Conclusion

Marco Torri's contributions to the field of pharmaceutical sciences through his patents and collaborations highlight his role as a key innovator. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…